Compare TTK HEALTHCARE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ABBOTT INDIA TTK HEALTHCARE/
ABBOTT INDIA
 
P/E (TTM) x 10.8 49.0 22.0% View Chart
P/BV x 1.6 15.8 9.9% View Chart
Dividend Yield % 1.0 0.4 227.2%  

Financials

 TTK HEALTHCARE   ABBOTT INDIA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
ABBOTT INDIA
Mar-19
TTK HEALTHCARE/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,2158,834 13.8%   
Low Rs6105,458 11.2%   
Sales per share (Unadj.) Rs444.41,731.1 25.7%  
Earnings per share (Unadj.) Rs17.2211.9 8.1%  
Cash flow per share (Unadj.) Rs27.6219.9 12.6%  
Dividends per share (Unadj.) Rs5.0065.00 7.7%  
Dividend yield (eoy) %0.50.9 60.2%  
Book value per share (Unadj.) Rs177.9945.2 18.8%  
Shares outstanding (eoy) m14.1321.25 66.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.14.1 49.8%   
Avg P/E ratio x52.933.7 156.9%  
P/CF ratio (eoy) x33.032.5 101.6%  
Price / Book Value ratio x5.17.6 67.8%  
Dividend payout %29.030.7 94.5%   
Avg Mkt Cap Rs m12,894151,848 8.5%   
No. of employees `0002.33.5 66.3%   
Total wages/salary Rs m1,3074,356 30.0%   
Avg. sales/employee Rs Th2,715.710,555.5 25.7%   
Avg. wages/employee Rs Th565.31,249.9 45.2%   
Avg. net profit/employee Rs Th105.41,292.2 8.2%   
INCOME DATA
Net Sales Rs m6,27936,786 17.1%  
Other income Rs m781,133 6.8%   
Total revenues Rs m6,35637,919 16.8%   
Gross profit Rs m4966,047 8.2%  
Depreciation Rs m147169 86.7%   
Interest Rs m3423 150.2%   
Profit before tax Rs m3936,989 5.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1492,485 6.0%   
Profit after tax Rs m2444,503 5.4%  
Gross profit margin %7.916.4 48.0%  
Effective tax rate %37.935.6 106.7%   
Net profit margin %3.912.2 31.7%  
BALANCE SHEET DATA
Current assets Rs m2,71727,610 9.8%   
Current liabilities Rs m1,5718,569 18.3%   
Net working cap to sales %18.351.8 35.3%  
Current ratio x1.73.2 53.7%  
Inventory Days Days3260 53.4%  
Debtors Days Days4727 170.3%  
Net fixed assets Rs m9911,057 93.8%   
Share capital Rs m141213 66.5%   
"Free" reserves Rs m2,37319,873 11.9%   
Net worth Rs m2,51420,086 12.5%   
Long term debt Rs m30-   
Total assets Rs m4,15829,409 14.1%  
Interest coverage x12.6311.6 4.0%   
Debt to equity ratio x00-  
Sales to assets ratio x1.51.3 120.7%   
Return on assets %6.715.4 43.4%  
Return on equity %9.722.4 43.2%  
Return on capital %16.934.9 48.5%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m225369 61.0%   
Fx outflow Rs m714,918 1.4%   
Net fx Rs m154-4,549 -3.4%   
CASH FLOW
From Operations Rs m1734,991 3.5%  
From Investments Rs m97-2,570 -3.8%  
From Financial Activity Rs m-307-1,428 21.5%  
Net Cashflow Rs m-38993 -3.8%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.7 7.9 46.8%  
FIIs % 5.2 0.1 5,200.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.1 150.9%  
Shareholders   12,723 18,270 69.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DR. REDDYS LAB  IPCA LABS  NATCO PHARMA  NEULAND LABS  PIRAMAL ENTERPRISES  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On...(Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Apr 16, 2021 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - STRIDES PHARMA SCIENCE COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS